Connexin 43 suppresses tumor angiogenesis by down-regulation of vascular endothelial growth factor via

Wei-Kuang Wang1, Man-Chin Chen2, Hon-Fai Leong3

  • 1Department of Environmental Engineering and Science, Feng Chia University, Taichung 40407, Taiwan. wkwang@fcu.edu.tw.

Insights

Connexin 43 (Cx43) inhibits tumor growth by reducing angiogenesis. Lower Cx43 levels increase vascular endothelial growth factor (VEGF), promoting tumor progression. This study highlights Cx43

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Connexin 43 (Cx43) has been shown to reduce the expression of hypoxia-induced factor-1α (HIF-1α) in astrocytes.
  • HIF-1α is a key transcription factor regulating angiogenesis, a process vital for tumor progression.

Purpose of the Study:

  • To investigate the role of Cx43 in regulating vascular endothelial growth factor (VEGF) production and angiogenesis in a murine tumor model.
  • To determine how Cx43 expression levels impact tumor cell behavior and the tumor microenvironment.

Main Methods:

  • Cx43 was overexpressed or knocked down in mouse B16F10 and 4T1 tumor cell lines.
  • VEGF expression, endothelial cell proliferation, and tumor angiogenesis were assessed in vitro and in vivo.
  • Cx43-overexpressing B16F10 cells were subcutaneously transplanted into mice to evaluate tumor growth and vascularization.

Main Results:

  • Reduced Cx43 expression in B16F10 and 4T1 cells led to increased VEGF expression and enhanced endothelial cell proliferation.
  • Conditioned medium from Cx43-knockdown tumor cells also increased VEGF expression and endothelial cell proliferation.
  • Subcutaneous tumors derived from Cx43-overexpressing cells exhibited significantly reduced tumor size and decreased vessel density compared to control groups.

Conclusions:

  • Cx43 plays an inhibitory role in tumor angiogenesis.
  • Cx43 suppresses tumor growth, at least in part, by reducing VEGF production and subsequent angiogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K